Everads Therapy-preview

Everads-therapy

Everads Therapy

Private

Tel AvivHealthcare & Life Scienceshttps://www.everads-therapy.com/

Last Round

Grant

Feb 1, 2020

Total Funding Raised

$140,000

Company Overview

Everads Therapy is a biotechnology company developing a novel delivery technology to treat retinal diseases via suprachoroidal administration.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

suprachoroidal deliverydrug delivery platformSCS deliveryretinal disease therapyocular drug deliverygene therapy deliverycell therapy deliverynon-surgical deliverydrug delivery licensingmedical device platformsuprachoroidal spaceoffice-based procedureposterior segment deliveryclinical-stage biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Everads Therapy Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Everads Therapy Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Feb 1, 2020
Accelerator	Jan 1, 2017

View all Funding Rounds

Key People

Founding team and executive leadership

Yonatan Cohavi

Chief Financial Officer

Executive Team

Everads Therapy Investors

Notable investors and investment history

Investor	Rounds
European Innovation Council	Grant
Israel Innovation Authority	Grant
RAD BioMed	Accelerator

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Mar 16, 2025
Monthly visitors increased 72% MoM.
Nov 11, 2024
Monthly visitors grew 833% MoM, from 150 to 1.4K.

View all signals

Everads Therapy Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Everads Therapy Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Everads Therapy's valuation, stock price, and market status.

Firmographic Details

HeadquartersTel Aviv

Employee Range9

Year Founded2017

Last FundingFeb 1, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.